首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   182篇
  免费   24篇
  2019年   2篇
  2017年   2篇
  2016年   3篇
  2015年   6篇
  2014年   8篇
  2013年   29篇
  2012年   4篇
  2011年   8篇
  2010年   4篇
  2009年   8篇
  2008年   6篇
  2007年   10篇
  2006年   6篇
  2005年   13篇
  2004年   5篇
  2003年   3篇
  2002年   3篇
  2000年   3篇
  1999年   2篇
  1998年   2篇
  1997年   2篇
  1996年   4篇
  1992年   2篇
  1989年   2篇
  1988年   3篇
  1987年   2篇
  1984年   2篇
  1982年   2篇
  1978年   2篇
  1975年   2篇
  1971年   2篇
  1915年   2篇
  1914年   1篇
  1909年   1篇
  1902年   1篇
  1901年   1篇
  1897年   2篇
  1892年   1篇
  1891年   1篇
  1889年   1篇
  1888年   1篇
  1887年   1篇
  1883年   3篇
  1882年   5篇
  1881年   2篇
  1880年   1篇
  1879年   6篇
  1878年   2篇
  1877年   2篇
  1876年   1篇
排序方式: 共有206条查询结果,搜索用时 15 毫秒
101.
102.
Previously we showed that intermittent administration of nicotine (NIC) in the dark phase decreased food intake and body weight and this could be blocked when the NIC receptor antagonist mecamylamine was infused into the fourth ventricle. Catecholaminergic neurons adjacent to the fourth ventricle contain NIC receptors and directly innervate the perifornical hypothalamus (PFH) which has been shown to be involved in regulation of feeding. This study explored whether NIC regulates feeding behavior by modulating catecholaminergic input to the PFH. Epinephrine and norepinephrine neuronal input was ablated within the PFH by infusion of 6-hydroxydopamine hydrobromide (6-OHDA), while bupropion was infused to protect dopaminergic neurons. After recovery of body weights to pre-surgery levels, food intake, meal size, meal number and body weight were measured after intermittent NIC injections. The results showed the PFH lesioned animals did not exhibit the typical prolonged drop in food intake, meal size and body weight normally associated with NIC administration. High performance liquid chromatography analyses demonstrated that compared to control rats, 6-OHDA administration significantly reduced PFH norepinephrine and epinephrine levels, but not dopamine levels. These results are consistent with NIC reducing food intake in part by acting through catecholaminergic neurons within or extending through the PFH.  相似文献   
103.
IntroductionAbatacept is a fusion protein of human cytotoxic T-lymphocyte–associated protein (CTLA)-4 and the Fc portion of human immunoglobulin G1 (IgG1). It is believed to be effective in the treatment of rheumatoid arthritis by inhibiting costimulation of T cells via blocking CD28–B7 interactions as CTLA-4 binds to both B7.1 (CD80) and B7.2 (CD86). However, the interaction of CD28 with B7 molecules is crucial for activation of naive cells, whereas it is unclear whether the action of already activated CD4+ T cells, which are readily present in established disease, also depends on this interaction. The aim of this study was to determine whether the mode of action of abatacept depends solely on its ability to halt T cell activation in established disease.MethodsArthritis was induced in thymectomized male DBA/1 mice by immunisation with bovine collagen type II. The mice were subsequently depleted for CD4+ T cells. Abatacept or control treatment was started when 80 % of the mice showed signs of arthritis. Arthritis severity was monitored by clinical scoring of the paws, and anti-collagen antibody levels over time were determined by enzyme-linked immunosorbent assay.ResultsTreatment with abatacept in the absence of CD4+ T cells resulted in lower disease activity. This was associated with decreasing levels of collagen-specific IgG1 and IgG2a antibodies, whereas the antibody levels in control or CD4+ T cell–depleted mice increased over time.ConclusionsThese results show that abatacept decreased disease activity in the absence of CD4+ T cells, indicating that the mode of action of abatacept in established arthritis does not depend entirely on its effects on CD4+ T cell activation.  相似文献   
104.
The European periwinkle snail, Littorina littorea was discovered in Pictou, NS, Canada in 1840. This snail’s subsequent rapid, conspicuous spread south from Pictou along the Canadian maritime coast and then along the New England and mid-Atlantic coast to New Jersey, its virtual absence in pre-European contact deposits, and its close association with human mechanisms of transport from Europe are among the clearest evidence for a human-mediated introduction. However, molecular genetic data have been proposed as evidence that L. littorea’s occurrence in North America was not the result of a human introduction by Wares et al. (Ecol Lett 5:577–584, 2002). Reexamination of these genetic data and reexamination of all other data available reveal that a human-mediated introduction of L. littorea is the simplest explanation of its occurrence in North America. The refutation of the human-mediated introduction of L. littorea was premature.  相似文献   
105.
Sepp1 supplies selenium to tissues via receptor-mediated endocytosis. Mice, rats, and humans have 10 selenocysteines in Sepp1, which are incorporated via recoding of the stop codon, UGA. Four isoforms of rat Sepp1 have been identified, including full-length Sepp1 and three others, which terminate at the second, third, and seventh UGA codons. Previous studies have shown that the longer Sepp1 isoforms bind to the low density lipoprotein receptor apoER2, but the mechanism remains unclear. To identify the essential residues for apoER2 binding, an in vitro Sepp1 binding assay was developed using different Sec to Cys substituted variants of Sepp1 produced in HEK293T cells. ApoER2 was found to bind the two longest isoforms. These results suggest that Sepp1 isoforms with six or more selenocysteines are taken up by apoER2. Furthermore, the C-terminal domain of Sepp1 alone can bind to apoER2. These results indicate that apoER2 binds to the Sepp1 C-terminal domain and does not require the heparin-binding site, which is located in the N-terminal domain. Site-directed mutagenesis identified three residues of Sepp1 that are necessary for apoER2 binding. Sequential deletion of extracellular domains of apoER2 surprisingly identified the YWTD β-propeller domain as the Sepp1 binding site. Finally, we show that apoER2 missing the ligand-binding repeat region, which can result from cleavage at a furin cleavage site present in some apoER2 isoforms, can act as a receptor for Sepp1. Thus, longer isoforms of Sepp1 with high selenium content interact with a binding site distinct from the ligand-binding domain of apoER2 for selenium delivery.  相似文献   
106.
107.
Immunohistochemistry for substance P (SP) in the rat thymus revealed fine varicose neural profiles in specific regions of the thymus. Thymic SP innervation was abundant within the capsule and interlobular septa. The majority of SP+ nerve fibers within the septa were free of vascular association, although some fibers were associated with the vasculature deep within the septa. SP+ nerve fibers entered the thymic cortex from the septa and distributed among cortical thymocytes and mast cells. Along the corticomedullary junction, SP+ nerve fibers were found in association with the vasculature. The medullary region of the thymus received only a sparse innervation of SP+ fibers. In addition, SP+ nerve fibers coursed adjacent to OX-8+ cells and mast cells in the extrathymic connective tissue surrounding the thymus. The present study provides evidence that SP is present in nerve fibers in the thymus, and may be available to interact with thymocytes, mast calls, and other cells in the thymus, and affect their development and function.  相似文献   
108.
109.
Two centuries of historical, archaeological, paleontological, geological, oceanographical and biological data conclusively indicate that the periwinkle snail Littorina littorea was introduced to North America from Europe either by Norse explorers 1000 years ago or by European colonists after 1840. Available genetic data do not indicate ancient divergence of North American and European L. littorea and thus do not challenge all other evidence that it was introduced from Europe by humans.  相似文献   
110.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号